Bleeding disorders in implant dentistry: a narrative review and a treatment guide

Purpose Considering a high prevalence of congenital and especially acquired bleeding disorders, their heterogeneity and the multitude of possible treatments strategies, a review of the scientific data on this topic is needed to implement a treatment guide for healthcare professionals. Methods A sele...

Full description

Saved in:
Bibliographic Details
Published in:International journal of implant dentistry 2022-04, Vol.8 (1), p.20-20, Article 20
Main Authors: Römer, Paul, Heimes, Diana, Pabst, Andreas, Becker, Philipp, Thiem, Daniel G. E., Kämmerer, Peer W.
Format: Article
Language:English
Subjects:
Algorithms
Anticoagulant
Antiplatelet drug
Bleeding
Bleeding disorder
Blood Coagulation Disorders - epidemiology
Coagulation
Congenital diseases
Dental implants
Dental Implants - adverse effects
Dental materials
Dentistry
Disorders
Factor deficiency
Hemophilia
Hemorrhage - therapy
Heterogeneity
Humans
Literature reviews
Medicine
Prospective Studies
Review
von Willebrand disease
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Considering a high prevalence of congenital and especially acquired bleeding disorders, their heterogeneity and the multitude of possible treatments strategies, a review of the scientific data on this topic is needed to implement a treatment guide for healthcare professionals. Methods A selective literature review was performed via PubMed for articles describing oral surgery / dental implant procedures in patients with congenital and acquired bleeding disorders. Out of the existing literature, potential treatment algorithms were extrapolated. Results In order to assess the susceptibility to bleeding, risk stratification can be used for both congenital and acquired coagulation disorders. This risk stratification, together with an appropriate therapeutic pathway, allows for an adequate and individualized therapy for each patient. A central point is the close interdisciplinary cooperation with specialists. In addition to the discontinuation or replacement of existing treatment modalities, local hemostyptic measures are of primary importance. If local measures are not sufficient, systemically administered substances such as desmopressin and blood products have to be used. Conclusions Despite the limited evidence, a treatment guide could be developed by means of this narrative review to improve safety for patients and practitioners. Prospective randomized controlled trials are needed to allow the implementation of official evidence-based guidelines.
ISSN:2198-4034
2198-4034
DOI:10.1186/s40729-022-00418-2